Back to Trades
Halladay Benjamin
Chief Financial OfficerCIK 0001953943
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 0
- Sell transactions
- 2
- Companies
- 1
- Active
- 2025–2026
Across 3 filings between 2025–2026, Halladay Benjamin, Chief Financial Officer, has disclosed $60.9K in transactions — all concentrated in Esperion Therapeutics, Inc. (ESPR). Their disclosed trades are heavily weighted toward selling — $0 in buys and $60.9K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Jul 13 | ESPR Esperion Therapeutics, Inc. | Halladay Benjamin | Chief Financial Officer | Disposed | $0 |
| Jun 18 | ESPR Esperion Therapeutics, Inc. | Halladay Benjamin | Chief Financial Officer | Sell | $34.0K |
| Dec 18 | ESPR Esperion Therapeutics, Inc. | Halladay Benjamin | Chief Financial Officer | Sell | $26.9K |
3 filings